Search results
Results From The WOW.Com Content Network
Top surgery involves more than a mastectomy for the treatment of breast cancer. [1] Special techniques are used to contour and reduce the chest wall, position the nipples and areola, and minimize scarring. [1] If the breast size is small, surgery that spares the skin, nipple and areola (subcutaneous nipple-sparing mastectomy) may be performed ...
v. t. e. Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine. [ 1][ 2][ 3] It is a common type ...
v. t. e. Gender-affirming surgery for male-to-female transgender women or transfeminine non-binary people describes a variety of surgical procedures that alter the body to provide physical traits more comfortable and affirming to an individual's gender identity and overall functioning. Often used to refer to vaginoplasty, sex reassignment ...
Gender-affirming surgery is a surgical procedure, or series of procedures, that alters a person's physical appearance and sexual characteristics to resemble those associated with their identified gender. The phrase is most often associated with transgender health care and intersex medical interventions, although many such treatments are also ...
Brian Czerniecki, MD, a surgical oncologist at Moffitt Cancer Center, agrees. “For years, we have known that there is no survival benefit to bilateral mastectomy,” he says. “Most do it for ...
Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine pattern of fat distribution. [ 4] Estrogens act by binding to and activating the estrogen receptor (ER), their biological target in the body. [ 14]
It's being used in brain tumors, head and neck cancers, and now increasingly also in breast cancer and prostate cancer," Mayo Clinic researcher and radiology oncologist Dr. Robert Mutter said.
Partial androgen insensitivity syndrome ( PAIS) is a condition that results in the partial inability of the cell to respond to androgens. [ 1][ 2][ 3] It is an X linked recessive condition. The partial unresponsiveness of the cell to the presence of androgenic hormones impairs the masculinization of male genitalia in the developing fetus, as ...